Paratek Pharmaceuticals Stock News

BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Wednesday, May 4 at 4:30

BOSTON, April 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-s

PRTK earnings call for the period ending December 31, 2021.

PRTK earnings call for the period ending December 31, 2021.

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript

Paratek Pharmaceuticals (NASDAQ: PRTK ) reported its Q4 earnings results on Monday, March 14, 2022 at 07:30 AM. Here''s what investors need to know about the announcement. Earnings Paratek Pharmaceuticals missed estimated earnings by 56.1%, reporting an EPS of $-0.64 versus … Full story available on Benzinga.com

Paratek Pharmaceuticals press release (PRTK): FY GAAP EPS of -$1.22 misses by $0.31.Revenue of $130.16M (+177.4% Y/Y) misses by $3.57M.

-- NUZYRA® (omadacycline) Generated Net U.S. Sales of $106.1 Million Comprised of $68.2 Million from the Core Commercial Business, a 76% increase over Prior Year, and $37.9 Million from the Initial P

Codiak BioSciences, Inc. (CDAK) delivered earnings and revenue surprises of 27.18% and 69.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s

BOSTON, March 02, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Monday, March 14 at 8:3

BOSTON, March 02, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Monday, March 14 at 8:30 a.m. EST to provide a corporate update and report its financial results for fourth quarter and full year 2021.

BOSTON, March 02, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Monday, March 14 at 8:30

Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter, compared to $2.56 in t

Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE: WSM ) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter, compared to $2.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $223.32 and a 52-week-low of $118.07. Williams-Sonoma closed at $163.67 at the end of the last trading period. For Lowe''s Companies Inc (NYSE: LOW ), Gordon Haskett upgraded the previous rating of Accumulate to Buy. In the third quarter, Lowe''s Companies showed an EPS of $2.73, compared to $1.98 from the year-ago quarter. The current stock performance of Lowe''s Companies shows a 52-week-high of $263.31 and a 52-week-low of $150.84. Moreover, at the end of the last trading period, the closing price was at $233.66. Daiwa Capital upgraded the previous rating for American Express Co (NYSE: AXP ) from Hold to Buy. In the fourth quarter, American Express showed an EPS of $2.18, compared to $1.76 from the year-ago quarter. The current stock performance of American Express shows a 52-week-high of $198.72 and a 52-week-low of $126.08.